Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...